Avalo Therapeutics Price Chart
*There is no price data available for this ticker
Avalo Therapeutics Volume Chart
*There is no volume data available for this ticker
Avalo Therapeutics Market Segments
Premarket
*No Trades in Segment
Overnight
*No Trades in Segment
After Hours Yesterday
+0.03(+0.17%)
| Open | $18.16 |
|---|---|
| Close | $18.19 |
| Low | $18.16 |
| Low Change | 0.00 (0.00%) |
| High | $18.19 |
| High Change | +0.03 (+0.17%) |
| Range | $0.03 |
| Volume | 169.69K |
| Dollar Volume | $3.09M |
Regular Trading Hours Yesterday
+0.13(+0.72%)
| Open | $18.06 |
|---|---|
| Close | $18.19 |
| Low | $17.78 |
| Low Change | -0.29 (-1.58%) |
| High | $18.44 |
| High Change | +0.38 (+2.10%) |
| Range | $0.67 |
| Volume | 1.102M |
| Dollar Volume | $20.05M |
Premarket Yesterday
+0.00(+0.00%)
| Open | $17.70 |
|---|---|
| Close | $17.70 |
| Low | $17.70 |
| Low Change | 0.00 (0.00%) |
| High | $17.70 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 200 |
| Dollar Volume | $3.54K |
Avalo Therapeutics News
2 months agobenzinga.comAvalo Therapeutics Stock Jumps 33% In Pre-Market Session: Here's Why
2 months agoinvesting.comAfter-hours movers: AMD, SMCI, GOOGL, AVTX, ANET, UPST, TEM
- 2 months agoinvesting.com
Avalo Therapeutics stock surges 35% on positive trial data
- 5 months agoinvesting.com
Avalo Therapeutics stock rises after Guggenheim initiates with Buy rating
Avalo Therapeutics Top Trades
We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.
Avalo Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $16.63 |
|---|---|
| 10 Day Moving Average (SMA10) | $15.36 |
| 20 Day Moving Average (SMA20) | $14.86 |
| 50 Day Moving Average (SMA50) | $15.68 |
| 100 Day Moving Average (SMA100) | $15.55 |
| 200 Day Moving Average (SMA200) | $15.64 |
Avalo Therapeutics Statistics
| Average Volume (30 Days) | 1.71M |
|---|---|
| P/E Ratio (Current) | -11.07 |
| EPS (Current) | -$1.61 |
| Dividend Yield | 0.00% |
| Free Cash Flow | — |
| Cash Ratio | 2.15 |
| Current Ratio | 7.65 |
| Quick Ratio | 7.65 |
| Debt to Equity | 0.00 |
| Enterprise Value | $912.26M |
| EV to EBITDA | -11.56 |
| EV to Sales | 15461.97 |
| Price to Book | 13.72 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 15885.49 |
| Return on Assets | -0.85% |
| Return on Equity | -1.24% |
Avalo Therapeutics Stock Splits
There have been 3 stock splits for Avalo Therapeutics (AVTX). The last reverse stock split occured on December 29, 2023 and reduced the outstanding shares at a ratio of 240:1.
| Date | Type | Ratio |
|---|---|---|
| Dec 29, 2023 | Reverse | 240:1 |
| Jul 8, 2022 | Reverse | 12:1 |
| Sep 10, 2007 | Reverse | 51:1 |
Avalo Therapeutics Dividends
There have been no dividends for Avalo Therapeutics (AVTX).